EDVA on NYSE

Endovia Health Sciences, Inc.

American beverages company that raised $41 million in 2025 (SEC Form D). Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with Accredited Solutions, Inc., LQR House Inc. or MDWerks, Inc., or pick any stock.

  • TickerEDVA on NYSE1
  • IndustryBeverages1
  • HeadquartersFort Lauderdale, Florida1
  • Incorporated inNV2
  • Business address1112 N Flagler Drive, Fort Lauderdale, Fl 333042
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

23.1%Gross margin3
-19415.6%Operating margin3
-34537.0%Net margin3
-90.9%Revenue growth, 20253

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

E commerce brought in 81% of the revenue Endovia Health Sciences, Inc. broke down this way in fiscal 2025.

  1. E commerce$59.0K381%down 91% from 2024
  2. Splash Beverage Group$14.1K319%down 91% from 2024
Products and services by year
Products and services20242025
E commerce$646.1K$59.0K
Splash Beverage Group$155.1K$14.1K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Interest100¢$2.5M

Out of $73.1K in revenue.3 The company lost money this year.

Financial statements

Revenue456783$73.1K in 2025+258% since 2019
0$5.0M$10.0M$15.0M$20.0M2019: $20.4K$20.4K20192020: $2.3M$2.3M2020+11182%2021: $11.3M$11.3M2021+392%2022: $18.1M$18.1M2022+60%2023: $18.9M$18.9M2023+4%2024: $801.3K$801.3K2024−96%2025: $73.1K$73.1K2025−91%
Gross profit456783$16.9K in 2025
-$2.0M0$2.0M$4.0M$6.0M2019: -$225.1K-$225.1K20192020: $363.6K$363.6K20202021: $3.9M$3.9M2021+978%2022: $5.9M$5.9M2022+51%2023: $5.6M$5.6M2023−6%2024: -$119.8K-$119.8K20242025: $16.9K$16.9K2025
Operating income456783-$14.2M in 2025+216% since 2019
-$30.0M-$20.0M-$10.0M02019: -$4.5M-$4.5M20192020: -$17.7M-$17.7M2020+294%2021: -$29.1M-$29.1M2021+65%2022: -$21.4M-$21.4M2022−26%2023: -$15.3M-$15.3M2023−29%2024: -$9.9M-$9.9M2024−35%2025: -$14.2M-$14.2M2025+43%
Net income46783-$25.2M in 2025+391% since 2019
-$30.0M-$20.0M-$10.0M02019: -$5.1M-$5.1M20192020: -$28.7M-$28.7M2020+458%2021: -$29.1M-$29.1M2021+1%2022: -$21.7M-$21.7M2022−25%2023: -$21.0M-$21.0M2023−3%2024: -$23.8M-$23.8M2024+13%2025: -$25.2M-$25.2M2025+6%
Fiscal year2019202020212022202320242025
Revenue$20.4K4$2.3M5$11.3M6$18.1M7$18.9M8$801.3K3$73.1K3
Cost of revenue$245.5K4$1.9M5$7.4M6$12.2M7$13.3M8$3.8M8
Gross profit-$225.1K4$363.6K5$3.9M6$5.9M7$5.6M8-$119.8K3$16.9K3
Selling, general and admin$204.1K11
Operating expenses$33.0M6$27.3M7$20.9M8$9.8M3$14.2M3
Operating income-$4.5M4-$17.7M5-$29.1M6-$21.4M7-$15.3M8-$9.9M3-$14.2M3
Interest$8.4K11$442.8K6$251.5K7$1.9M8$3.7M3$2.5M3
Income tax$011$05$06$07$08$03$03
Net income-$5.1M4-$28.7M4-$29.1M6-$21.7M7-$21.0M8-$23.8M3-$25.2M3
Earnings per share-$0.0411-$1.065-$1.025-$17.683-$11.973
Earnings per share (diluted)-$0.0411-$1.065-$1.025-$17.683-$11.973
Shares (weighted, basic)37.4M shares71.1M shares81.3M shares32.2M shares3
Shares (weighted, diluted)28.9M shares537.4M shares71.1M shares81.3M shares32.2M shares3

Compare Endovia Health Sciences, Inc. with another company

Leadership

Who has led Endovia Health Sciences, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Michael J. West2014
  2. Heather Kearns2019
  3. Robert Nistico2020–2026
  4. Brady James Cobb2026–now

Chair

  1. Robert Nistico2020–now

President

  1. Michael J. West2014
  2. Robert Nistico2020–2022
  3. William R. Meissner2022–now

Chief financial officer

  1. Stephen H. West2014
  2. Dean Scott Huge2020
  3. Fatima Dhalla2022–2023
  4. Ronald Charles Wall2022–2023
  5. Stacy B. McLaughlin2024
  6. Julius Paul Ivancsits2024
  7. William T. Devereux2025–now

Chief operating officer

  1. Michael Breen Bondurant2026–now
201520202025
Board members and other officers (13)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerWilliam Devereaux named Jul 8, 202535
  • DirectorBill Caple named Jul 8, 202535

Former names

  • SPLASH BEVERAGE GROUP, INC.Aug 13, 2020 to Aug 21, 20262
  • Canfield Medical Supply, Inc.Jul 12, 2012 to Aug 5, 20202

Timeline

  1. Jun 10, 2026New chief executive Brady James Cobb becomes CEO12
  2. Apr 9, 2020New chief executive Robert Nistico becomes CEO13
  3. Jul 10, 2019New chief executive Heather Kearns becomes CEO14
  4. Apr 10, 2014New chief executive Michael J. West becomes CEO15

Filings

252 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 99 major events, 49 insider forms, 11 large holders, 5 private raises, 67 other. The latest 20:

  1. Oct 15, 20268-K EDGAR
  2. Oct 8, 2026DEFA14A EDGAR
  3. Oct 6, 20268-K EDGAR
  4. Oct 5, 2026DEF 14A EDGAR
  5. Oct 5, 20268-K EDGAR
  6. Sep 24, 20268-K EDGAR
  7. Sep 23, 2026PRE 14A EDGAR
  8. Sep 22, 20268-K EDGAR
  9. Sep 18, 2026PRE 14A EDGAR
  10. Aug 31, 20268-K EDGAR
  11. Aug 28, 20268-K EDGAR
  12. Aug 28, 2026424B3 EDGAR
  13. Aug 26, 20268-K EDGAR
  14. Aug 25, 20268-K EDGAR
  15. Aug 24, 2026EFFECT EDGAR
  16. Aug 21, 20268-K EDGAR
  17. Aug 20, 2026S-1/A FORM S-1/A1 EDGAR
  18. Aug 20, 20268-K EDGAR
  19. Aug 19, 202610-Q EDGAR
  20. Aug 17, 2026NT 10-Q EDGAR

The 252 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

8 open-market trades by officers, directors and large owners since October 2021: 8 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 16, 2023Nistico RobertCEO and ChairmanBuy7,000$1.01$7.1KForm 4
Apr 14, 2023Nistico RobertCEO and ChairmanBuy12,000$1.15$13.8KForm 4
Apr 13, 2023Nistico RobertCEO and ChairmanBuy17,000$1.17$19.9KForm 4
Jun 16, 2022Nistico RobertCEO and ChairmanBuy3,000$1.68$5.0KForm 4
Jun 15, 2022Nistico RobertCEO and ChairmanBuy1,000$1.83$1.8KForm 4
Jun 3, 2022Nistico RobertCEO and ChairmanBuy2,000$2.06$4.1KForm 4
May 27, 2022Nistico RobertCEO and ChairmanBuy4,000$2.08$8.3KForm 4
May 26, 2022Nistico RobertCEO and ChairmanBuy7,000$1.96$13.7KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Jun 25, 2025Raised $33.3 million in a private offering of equity Form D: $36.2 million offered in all Form D
  2. Aug 22, 2024Raised $600,000 in a private offering of securities Form D: 2 investors so far Form D
  3. May 1, 2024Raised $1.9 million in a private offering of securities Form D: 3 investors so far Form D
  4. Oct 5, 2023Raised $1.2 million in a private offering of securities Form D: 3 investors so far Form D
  5. Dec 27, 2022Raised $4 million in a private offering of equity Form D: 8 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Harbour Investments, Inc.470$730.0%New

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44